Table of Contents Author Guidelines Submit a Manuscript
Cellular Oncology
Volume 30, Issue 4, Pages 307-322
http://dx.doi.org/10.3233/CLO-2008-0427

Mitochondrial DNA Depletion Reduces PARP-1 Levels and Promotes Progression of the Neoplastic Phenotype in Prostate Carcinoma

Loredana Moro,1 Arnaldo A. Arbini,2 Ersilia Marra,1 and Margherita Greco1

1Institute of Biomembranes and Bioenergetics, National Research Council (CNR), Bari 70126, Italy
2Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA

Copyright © 2008 Hindawi Publishing Corporation and the authors. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [38 citations]

The following is the list of published articles that have cited the current article.

  • Yujiro Shidara, Takashi Tajiri, Satoshi Mizutani, Yasuyuki Miyato, Akira Tokunaga, Shigeo Ohta, and Sadamitsu Asoh, “Mutations in the mitochondrial genome confer resistance of cancer cells to anticancer drugs,” Cancer Science, vol. 100, no. 9, pp. 1680–1687, 2009. View at Publisher · View at Google Scholar
  • Flora Guerra, Flavio Fracasso, Palmiro Cantatore, Luigi Selvaggi, Antonella Cormio, Vito Pesce, Gennaro Cormio, Vera Loizzi, and Maria Nicola Gadaleta, “The PGC-1α-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer,” Biochemical and Biophysical Research Communications, vol. 390, no. 4, pp. 1182–1185, 2009. View at Publisher · View at Google Scholar
  • Yurong Shi, Yi Yang, Man Yu, Xiyin Wei, Fenglin Zang, and Ruifang Niu, “Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47D breast cancer cells,” European Journal of Cancer Prevention, vol. 18, no. 6, pp. 445–457, 2009. View at Publisher · View at Google Scholar
  • Moro, Marra, di Sant'Agnese, Arbini, Greco, and Yao, “Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2,” Cell Death and Differentiation, vol. 16, no. 4, pp. 571–583, 2009. View at Publisher · View at Google Scholar
  • Asghar Hajibeigi, Loredana Moro, Evan R. Simpson, Orhan K. Öz, Arnaldo A. Arbini, Jer-Tsong Hsieh, and Jeffery Ford, “Aromatase deficiency inhibits the permeability transition in mouse liver mitochondria,” Endocrinology, vol. 151, no. 4, pp. 1643–1652, 2010. View at Publisher · View at Google Scholar
  • Gianni Celsi, Katarina Carlsson, Svante Norgren, Ming Chen, and Xuezhong Gong, “N-acetylcysteine amide protects renal proximal tubular epithelial cells against iohexol-induced apoptosis by blocking p38 MAPK and iNOS signaling,” American Journal of Nephrology, vol. 31, no. 2, pp. 178–188, 2010. View at Publisher · View at Google Scholar
  • Cynthia LeBron, Jatin K. Nagpal, Keishi Yamashita, Juna Lee, Yiping Huang, Edward A. Ratovitski, David Sidransky, Xiaofei Chang, Myoung Sook Kim, and Barry Trink, “Neurofilament heavy polypeptide regulates the Akt-β-catenin pathway in human esophageal squamous cell carcinoma,” PLoS ONE, vol. 5, no. 2, 2010. View at Publisher · View at Google Scholar
  • Rafael Moreno-Sánchez, Emma Saavedra, Sara Rodríguez-Enríquez, Juan Carlos Gallardo-Pérez, Héctor Quezada, and Hans V. Westerhoff, “Metabolic control analysis indicates a change of strategy in the treatment of cancer,” Mitochondrion, vol. 10, no. 6, pp. 626–639, 2010. View at Publisher · View at Google Scholar
  • Robert Monks, Ji-Kang Fang, Manti Guha, Narayan G. Avadhani, and Morris J. Birnbaum, “Activation of Akt is essential for the propagation of mitochondrial respiratory stress signaling and activation of the transcriptional coactivator heterogeneous ribonucleoprotein A2,” Molecular Biology of the Cell, vol. 21, no. 20, pp. 3578–3589, 2010. View at Publisher · View at Google Scholar
  • Man Yu, Qinghua Zou, and Yanfang Wan, “Decreased copy number of mitochondrial DNA in ewing's sarcoma,” Clinica Chimica Acta, vol. 411, no. 9-10, pp. 679–683, 2010. View at Publisher · View at Google Scholar
  • Gabriel D. Dakubopp. 1–356, 2010. View at Publisher · View at Google Scholar
  • Gulcan Akgul, Gunhild M. Mælandsmo, Fahri Saatcioglu, Mari Kaarbø, Su Qu, Viola H. Lobert, Thomas Halvorsen, Lene Malerød, and Øyvind Løveseter Mikkelsen, “PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells,” Cellular Oncology, vol. 32, no. 1-2, pp. 11–27, 2010. View at Publisher · View at Google Scholar
  • Damien Bolton, Gillian Mitchell, Amber J. Willems, Ivan M. Y. Hoh, Jason Li, John L. Hopper, Heather Thorne, Eveline Niedermayr, David Clouston, and Stephen Fox, “Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families,” Cancer Prevention Research, vol. 4, no. 7, pp. 1002–1010, 2011. View at Publisher · View at Google Scholar
  • Man Yu, “Generation, function and diagnostic value of mitochondrial DNA copy number alterations in human cancers,” Life Sciences, vol. 89, no. 3-4, pp. 65–71, 2011. View at Publisher · View at Google Scholar
  • Dhyan Chandra, and Keshav K. Singh, “Genetic insights into OXPHOS defect and its role in cancer,” Biochimica et Biophysica Acta - Bioenergetics, vol. 1807, no. 6, pp. 620–625, 2011. View at Publisher · View at Google Scholar
  • Flora Guerra, Giuseppe Gasparre, Roberta Zuntini, Laura Benedetta Amato, Donatella Santini, Flavio Fracasso, Marcella Attimonelli, Maria Nicola Gadaleta, Antonella Cormio, Gennaro Cormio, Luigi Selvaggi, Claudio Ceccarelli, Leonardo Resta, and Ivana Kurelac, “Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma,” Human Molecular Genetics, vol. 20, no. 12, pp. 2394–2405, 2011. View at Publisher · View at Google Scholar
  • Paul A. Di Sant'Agnese, Arnaldo A. Arbini, Patricia Bourne, Margherita Greco, Jorge L. Yao, Jer-Tsong Hsieh, Ersilia Marra, and Loredana Moro, “Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer,” American Journal of Pathology, vol. 178, no. 5, pp. 2367–2376, 2011. View at Publisher · View at Google Scholar
  • Masahiro Higuchi, and Cody C. Cook, “The awakening of an advanced malignant cancer: An insult to the mitochondrial genome,” Biochimica et Biophysica Acta - General Subjects, vol. 1820, no. 5, pp. 652–662, 2012. View at Publisher · View at Google Scholar
  • Sergio Giannattasio, Nicoletta Guaragnella, Arnaldo A. Arbini, and Loredana Moro, “Stress-Related Mitochondrial Components and Mitochondrial Genome as Targets of Anticancer Therapy,” Chemical Biology & Drug Design, vol. 81, no. 1, pp. 102–112, 2012. View at Publisher · View at Google Scholar
  • Teruya Kawamoto, Kenta Kishimoto, Risa Harada, Masaya Minoda, Takeshi Ueha, Hitomi Hara, Mitsunori Toda, Yasuo Onishi, Yoshitada Sakai, Masahiko Miwa, Masahiro Kurosaka, Toshihiro Akisue, and Naomasa Fukase, “Transcutaneous Application of Carbon Dioxide (CO2) Induces Mitochondrial Apoptosis in Human Malignant Fibrous Histiocytoma In Vivo,” PLoS ONE, vol. 7, no. 11, 2012. View at Publisher · View at Google Scholar
  • Man Yu, and Man Yu, “Somatic Mitochondrial DNA Mutations in Human Cancers,” Advances in Clinical Chemistry, vol. 57, pp. 99–138, 2012. View at Publisher · View at Google Scholar
  • Antonella Cormio, Luigi Eustacchio Selvaggi, Vito Pesce, Maria Nicola Gadaleta, Gennaro Cormio, Vera Loizzi, Leonardo Resta, Flora Guerra, Flavio Fracasso, Giuseppe Putignano, and Palmiro Cantatore, “Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium,” BMC Research Notes, vol. 5, 2012. View at Publisher · View at Google Scholar
  • Shahriar Koochekpour, Keshav K. Singh, Timothy Marlowe, Kristopher Attwood, and Dhyan Chandra, “Reduced Mitochondrial DNA Content Associates with Poor Prognosis of Prostate Cancer in African American Men,” PLoS ONE, vol. 8, no. 9, 2013. View at Publisher · View at Google Scholar
  • Alfonso F. Davila, and Pedro Zamorano, “Mitochondria and the evolutionary roots of cancer,” Physical Biology, vol. 10, no. 2, 2013. View at Publisher · View at Google Scholar
  • Man Yu, Yanfang Wan, and Qinghua Zou, “Reduced mitochondrial DNA copy number in Chinese patients with osteosarcoma,” Translational Research, vol. 161, no. 3, pp. 165–171, 2013. View at Publisher · View at Google Scholar
  • Laimonas Kelbauskas, Xu Shi, Roger H. Johnson, Deirdre R. Meldrum, Weiwen Zhang, and Jiangxin Wang, “Single-Cell Analysis Reveals Early Manifestation of Cancerous Phenotype in Pre-Malignant Esophageal Cells,” PLoS ONE, vol. 8, no. 10, 2013. View at Publisher · View at Google Scholar
  • Suzana Kovac, Damien Bolton, Carine Michiels, Graham S. Baldwin, Oneel Patel, Arthur Shulkes, Weranja K. B. Ranasinghe, Lin Xiao, and Mike Chang, “The Role of Hypoxia-Inducible Factor 1α in Determining the Properties of Castrate-Resistant Prostate Cancers,” PLoS ONE, vol. 8, no. 1, 2013. View at Publisher · View at Google Scholar
  • Greco, Arbini, Guerra, Gandee, Lotan, Gasparre, Moro, Marra, Xiao, and Hsieh, “Mitochondrial DNA depletion sensitizes cancer cells to PARP inhibitors by translational and post-translational repression of BRCA2,” Oncogenesis, vol. 2, 2013. View at Publisher · View at Google Scholar
  • Nicoletta Guaragnella, Sergio Giannattasio, and Loredana Moro, “Mitochondrial dysfunction in cancer chemoresistance,” Biochemical Pharmacology, vol. 92, no. 1, pp. 62–72, 2014. View at Publisher · View at Google Scholar
  • Huakang Tu, Xifeng Wu, Jian Gu, Qing H. Meng, Jeri Kim, John W. Davis, Yonggang He, Elizabeth A. Wagar, Timothy C. Thompson, and Christopher J. Logothetis, “Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer,” Oncotarget, vol. 6, no. 39, pp. 41988–41996, 2015. View at Publisher · View at Google Scholar
  • Inna N. Shokolenko, Glenn L. Wilson, and Mikhail F. Alexeyev, “The "fast'' and the "slow'' modes of mitochondrial DNA degradation,” Mitochondrial Dna, vol. 27, no. 1, pp. 490–498, 2016. View at Publisher · View at Google Scholar
  • Jayoung Kim, and Wun-Jae Kim, “Looking to the metabolic landscapes for prostate health monitoring,” Prostate International, vol. 5, no. 3, pp. 85–88, 2017. View at Publisher · View at Google Scholar
  • Giulia Girolimetti, Giuseppe Gasparre, Flora Guerra, Michele Maffia, Michele Vidone, Sabrina Dusi, Valeria Tiranti, Anna Myriam Perrone, Cecilia Bucci, Anna Maria Porcelli, Luisa Iommarini, Ivana Kurelac, Daniele Vergara, Laura Benedetta Amato, and Giulia Leone, “Platinum-induced mitochondrial DNA mutations confer lower sensitivity to paclitaxel by impairing tubulin cytoskeletal organization,” Human Molecular Genetics, vol. 26, no. 15, pp. 2961–2974, 2017. View at Publisher · View at Google Scholar
  • Xiaoran Li, Jie Lu, Quancheng Kan, Xiaoli Li, Qiong Fan, Yaqing Li, Ruixia Huang, Ana Slipicevic, Hiep Phuc Dong, Lars Eide, Junbai Wang, Hongquan Zhang, Viktor Berge, Mariusz Adam Goscinski, Gunnar Kvalheim, Jahn M. Nesland, and Zhenhe Suo, “Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Flora Guerra, Arnaldo A. Arbini, and Loredana Moro, “Mitochondria and cancer chemoresistance,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, 2017. View at Publisher · View at Google Scholar
  • Arnaldo A. Arbini, Cecilia Bucci, Sergio Giannattasio, Flora Guerra, Nicoletta Guaragnella, and Loredana Moro, “Mitochondrial dysfunction: A novel potential driver of epithelial-to-mesenchymal transition in cancer,” Frontiers in Oncology, vol. 7, 2017. View at Publisher · View at Google Scholar
  • Sung Han Kim, Jae Young Joung, Weon Seo Park, Ho Kyung Seo, Won Hoon Song, Jinsoo Chung, and Kang Hyun Lee, “Prostate cancer in a patient with a family history of BRCA mutation: A case report and literature review,” Journal of Korean Medical Science, vol. 32, no. 2, pp. 377–381, 2017. View at Publisher · View at Google Scholar
  • James G. Kench, Vanessa M. Hayes, Eva K. F. Chan, Judith Grogan, Desiree C. Petersen, Ruta Gupta, Ruth J. Lyons, Lisa G. Horvath, Anton M. F. Kalsbeek, Phillip D. Stricker, Weerachai Jaratlerdsiri, and Anne-Maree Haynes, “Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer,” Prostate, vol. 78, no. 1, pp. 25–31, 2018. View at Publisher · View at Google Scholar